Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Huge rotating structure of galaxies and dark matter is detected - 280 km. on foot: Sharren Haskel’s three-day march in protest of haredi draft bill
- 3Allow Innovative Progressions To have a Tremendous Effect
- 4Defence chiefs of Thailand and Cambodia to discuss ceasefire
- 5The Most recent Microsoft Surface Genius PC: Ideal for Very good quality Planning and Gaming Needs
- 21 Things You Ought to Never Tell Your Childless Companion
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- Productive CRM Programming for Client Relationship The executives
- Which Exhibition hall Do You Suggest? Vote
- From Novice to Master: Dominating a Side interest
- The Most Encouraging New companies to Look Out For
- Treasure trove found in Egyptian tomb solves ancient mystery
- Alleged maple syrup scam in Quebec uncovered by Canadian broadcaster
- In a first, scientists observe a comet reversing its spin
